Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,481 to 1,500 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Programmed cell death ligand 1 expression in cytologic and surgical non-small cell lung carcinoma specimens from a single institution: Association with clinicopathologic features and molecular alterations. | Cancer Cytopathol | 2019 | 31025831 | PubTator, text mining | PubMed |
| Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors: Small Steps Toward Personalized Medicine? | Epigenet Insights | 2019 | 31020269 | PubTator, text mining | PubMed |
| DDR2-CYR61-MMP1 Signaling Pathway Promotes Bone Erosion in Rheumatoid Arthritis Through Regulating Migration and Invasion of Fibroblast-Like Synoviocytes. | J Bone Miner Res | 2019 | 31018030 | PubTator, text mining | PubMed |
| High-Fat Diet Alters Immunogenic Properties of Circulating and Adipose Tissue-Associated Myeloid-Derived CD45+DDR2+ Cells. | Mediators Inflamm | 2019 | 31015794 | PubTator, text mining | PubMed |
| Dynamic fibroblast contractions attract remote macrophages in fibrillar collagen matrix. | Nat Commun | 2019 | 31015429 | PubTator, text mining | PubMed |
| Orthotopic Patient-Derived Xenografts of Gastric Cancer to Decipher Drugs Effects on Cancer Stem Cells and Metastatic Dissemination. | Cancers (Basel) | 2019 | 31010193 | PubTator, text mining | PubMed |
| miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma. | Mol Ther Nucleic Acids | 2019 | 31009917 | PubTator, text mining | PubMed |
| A structural prospective for collagen receptors such as DDR and their binding of the collagen fibril. | Biochim Biophys Acta Mol Cell Res | 2019 | 31004686 | PubTator, text mining | PubMed |
| Discoidin domain receptor 2: An emerging pharmacological drug target for prospective therapy against osteoarthritis. | Pharmacol Rep | 2019 | 31003149 | PubTator, text mining | PubMed |
| AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy. | Nat Commun | 2019 | 31000705 | PubTator, text mining | PubMed |
| Mesenchymal stem cells: From regeneration to cancer. | Pharmacol Ther | 2019 | 30998940 | PubTator, text mining | PubMed |
| Cellular Plasticity in Cancer. | Cancer Discov | 2019 | 30992279 | PubTator, text mining | PubMed |
| The role and mechanism of transforming growth factor beta 3 in human myocardial infarction-induced myocardial fibrosis. | J Cell Mol Med | 2019 | 30983140 | PubTator, text mining | PubMed |
| An Integrated Next-Generation Sequencing System for Analyzing DNA Mutations, Gene Fusions, and RNA Expression in Lung Cancer. | Transl Oncol | 2019 | 30981944 | PubTator, text mining | PubMed |
| Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. | Int J Mol Sci | 2019 | 30970564 | PubTator, text mining | PubMed |
| The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. | Int J Mol Sci | 2019 | 30959975 | PubTator, text mining | PubMed |
| Dichotomy of the function of DDR1 in cells and disease progression. | Biochim Biophys Acta Mol Cell Res | 2019 | 30954568 | PubTator, text mining | PubMed |
| Embryonic stem cell- and transcriptomics-based in vitro analyses reveal that bisphenols A, F and S have similar and very complex potential developmental toxicities. | Ecotoxicol Environ Saf | 2019 | 30951980 | PubTator, text mining | PubMed |
| Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure. | Curr Drug Metab | 2019 | 30947665 | PubTator, text mining | PubMed |
| Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today? | Front Oncol | 2019 | 30941314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=75